AI
Wednesday, April 13, 2011 7:54:42 PM
SNY won't admit it but they had a shortage for all syringe doses especially the HD syringes because they were anticipating a TEVA entry that never came into fruition..
So all along TEVA has been secretly helping MNTA out by the BS "we will be approved next month" claims.
Is there any "stickyness" in this effect? Once the shortage is over will there be less of a gap between the product price/demand curves than there would have been w/o the shortage?
Might Sandoz need to raise prices a bit?
So all along TEVA has been secretly helping MNTA out by the BS "we will be approved next month" claims.
Is there any "stickyness" in this effect? Once the shortage is over will there be less of a gap between the product price/demand curves than there would have been w/o the shortage?
Might Sandoz need to raise prices a bit?
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
